×
About 601 results

ALLMedicine™ Alveolar Soft Part Sarcoma Center

Research & Reviews  295 results

Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of...
https://doi.org/10.1007/s10637-021-01105-6 10.1002/1097-0142(195201)5:1<100::AID-CNCR2820050112>3.0.CO;2-K 10.1016/j.biopha.2018.04.117 10.1155/2012/428789 10.1001/jamaoncol.2018.4490 10.1016/S0761-8425(09)72591-4 10.1186/s13000-015-0399-5 10.3346/jkms.2007.22.2.369 10.1002/jso.24183 10.5301/tj.5000617 10.1002/pbc.24683 10.1002/hed.23648 10.1002/pbc.27405 10.1002/pbc.26953 10.1158/1078-0432.CCR-17-3766 10.1200/JCO.2018.36.15_suppl.11503 10.1007/s10637-016-0390-3 10.2147/TCRM.S84792 10.1016/j.jchromb.2012.06.004 10.1634/theoncologist.2018-0464 10.1634/theoncologist.2017-0161 10.1016/s1470-2045(19)30215-3 10.1200/JCO.2018.36.15_suppl.10540 10.18632/oncotarget.18599 10.1093/annonc/mdx774 10.1038/s41416-018-0100-3 10.3390/molecules24112071 10.1200/JCO.18.02151 10.1158/1078-0432.CCR-19-1680 10.1007/s40265-019-01167-0 10.21037/apm-20-2275 10.1016/j.ijrobp.2018.07.538 10.1200/JCO.2019.37.15_suppl.4031 10.1093/annonc/mdy424.029 10.1158/1078-0432.CCR-18-2484 10.1200/JCO.2018.36.15_suppl.e21017 10.1016/S1470-2045(18)30579-5 10.1056/NEJMra1703481 10.1016/S1470-2045(19)30153-6 10.1158/2326-6066.CIR-18-0037 10.1200/JCO.2018.36.15_suppl.11572
Investigational New Drugs; Su H, Yu C et. al.

Mar 25th, 2021 - Primary acinar soft part sarcoma of the lung (ASPS) is a rare malignancy with unique cellular structure and clinical and genetic characteristics. Most patients do not exhibit clear clinical symptoms, with only a few developing respiratory symptoms...

Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined ...
https://doi.org/10.21037/apm-20-2275
Annals of Palliative Medicine; Xu Z, Zhang Y et. al.

Feb 6th, 2021 - Alveolar soft part sarcoma (ASPS) is a rare and highly malignant mesenchymal tumor that primarily affects adolescents and young adults. ASPS is characterized by a slow growth rate, high metastatic potential, and resistance to conventional therapie...

Alveolar soft part sarcoma presenting in an unusual laryngeal location.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797268
BMJ Case Reports; Jang S, Emanuel A et. al.

Jan 8th, 2021 - Alveolar soft part sarcoma (ASPS) is a rare malignant neoplasm that tends to occur in the deep soft tissues of both adults and children. ASPS has a progressive clinical course that is unfortunately characterised by late metastases and an overall p...

Immune Checkpoint Inhibitors in Alveolar Soft Part Sarcoma: New Standard of Care?
https://doi.org/10.1089/jayao.2020.0167
Journal of Adolescent and Young Adult Oncology; Mittal A, Arun Raj ST et. al.

Dec 16th, 2020 - Immune Checkpoint Inhibitors in Alveolar Soft Part Sarcoma: New Standard of Care?|2020|Mittal A,Arun Raj ST,Gupta A,Shamim SA,Barwad A,|

see more →

Clinicaltrials.gov  303 results

Combined immunotherapy and targeted treatment for primary alveolar soft part sarcoma of...
https://doi.org/10.1007/s10637-021-01105-6 10.1002/1097-0142(195201)5:1<100::AID-CNCR2820050112>3.0.CO;2-K 10.1016/j.biopha.2018.04.117 10.1155/2012/428789 10.1001/jamaoncol.2018.4490 10.1016/S0761-8425(09)72591-4 10.1186/s13000-015-0399-5 10.3346/jkms.2007.22.2.369 10.1002/jso.24183 10.5301/tj.5000617 10.1002/pbc.24683 10.1002/hed.23648 10.1002/pbc.27405 10.1002/pbc.26953 10.1158/1078-0432.CCR-17-3766 10.1200/JCO.2018.36.15_suppl.11503 10.1007/s10637-016-0390-3 10.2147/TCRM.S84792 10.1016/j.jchromb.2012.06.004 10.1634/theoncologist.2018-0464 10.1634/theoncologist.2017-0161 10.1016/s1470-2045(19)30215-3 10.1200/JCO.2018.36.15_suppl.10540 10.18632/oncotarget.18599 10.1093/annonc/mdx774 10.1038/s41416-018-0100-3 10.3390/molecules24112071 10.1200/JCO.18.02151 10.1158/1078-0432.CCR-19-1680 10.1007/s40265-019-01167-0 10.21037/apm-20-2275 10.1016/j.ijrobp.2018.07.538 10.1200/JCO.2019.37.15_suppl.4031 10.1093/annonc/mdy424.029 10.1158/1078-0432.CCR-18-2484 10.1200/JCO.2018.36.15_suppl.e21017 10.1016/S1470-2045(18)30579-5 10.1056/NEJMra1703481 10.1016/S1470-2045(19)30153-6 10.1158/2326-6066.CIR-18-0037 10.1200/JCO.2018.36.15_suppl.11572
Investigational New Drugs; Su H, Yu C et. al.

Mar 25th, 2021 - Primary acinar soft part sarcoma of the lung (ASPS) is a rare malignancy with unique cellular structure and clinical and genetic characteristics. Most patients do not exhibit clear clinical symptoms, with only a few developing respiratory symptoms...

Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined ...
https://doi.org/10.21037/apm-20-2275
Annals of Palliative Medicine; Xu Z, Zhang Y et. al.

Feb 6th, 2021 - Alveolar soft part sarcoma (ASPS) is a rare and highly malignant mesenchymal tumor that primarily affects adolescents and young adults. ASPS is characterized by a slow growth rate, high metastatic potential, and resistance to conventional therapie...

Alveolar soft part sarcoma presenting in an unusual laryngeal location.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797268
BMJ Case Reports; Jang S, Emanuel A et. al.

Jan 8th, 2021 - Alveolar soft part sarcoma (ASPS) is a rare malignant neoplasm that tends to occur in the deep soft tissues of both adults and children. ASPS has a progressive clinical course that is unfortunately characterised by late metastases and an overall p...

Immune Checkpoint Inhibitors in Alveolar Soft Part Sarcoma: New Standard of Care?
https://doi.org/10.1089/jayao.2020.0167
Journal of Adolescent and Young Adult Oncology; Mittal A, Arun Raj ST et. al.

Dec 16th, 2020 - Immune Checkpoint Inhibitors in Alveolar Soft Part Sarcoma: New Standard of Care?|2020|Mittal A,Arun Raj ST,Gupta A,Shamim SA,Barwad A,|

see more →

News  3 results

TKIs and immunotherapy hold promise for alveolar soft part sarcoma
https://www.mdedge.com/sarcomajournal/article/177893/sarcoma-gist/tkis-and-immunotherapy-hold-promise-alveolar-soft-part
Roxanne Nelson

Oct 23rd, 2018 - Alveolar soft part sarcoma (ASPS) has often proven to be resistant to conventional doxorubicin-based chemotherapy, but tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) may provide new treatment strategies for this rare typ.

Primary Alveolar Soft Part Sarcoma of Chest Wall: A Case Report and Review of the Literature
https://www.medscape.com/viewarticle/533958_3

Jul 4th, 2006 - Discussion The exact cause of ASPS is not entirely understood; however, studies indicate that genetic alterations may play a role. Certain inherited conditions are associated with an increased risk of developing soft-tissue sarcomas, including Li-...

Primary Alveolar Soft Part Sarcoma of Chest Wall: A Case Report and Review of the Literature
https://www.medscape.com/viewarticle/533958

Jul 4th, 2006 - Introduction Alveolar soft part sarcoma (ASPS), also called alveolar soft-tissue sarcoma (ASTS), is a rare malignant soft-tissue neoplasm, which was first described by Christopherson and colleagues[1] in 1952. Its prevalence is less than 1% of all...

see more →